A recent editorial highlights the value of personalized screening recommendations for CHEK2 carriers
▪️ Notably, three common low-risk mutations (p.I157T, p.S428F, and p.T476M) impart a breast cancer risk of less than 1.4 fold
▪️ This level of risk does not warrant high-risk breast screening or other heightened care
Read the full article to learn more at: https://www.oncotarget.com/article/28604/pdf/
Reference: Hernandez et al. Oncotarget. 2024:15:459-460. PMID: 38985133.